Brief: Diamedica Therapeutics Provides A Business Update And Announces First Quarter 2021 Financial Results
05/05/2021 22:00
May 5 (Reuters) - DiaMedica Therapeutics Inc DMAC.O :
* DIAMEDICA THERAPEUTICS PROVIDES A BUSINESS UPDATE AND
ANNOUNCES
FIRST QUARTER 2021 FINANCIAL RESULTS
* PLAN TO INITIATE PHASE 2/3 AIS TRIAL IN SUMMER 2021
* CASH RUNWAY THROUGH MID-2022
* QTRLY LOSS PER SHARE $0.19
* Q1 EARNINGS PER SHARE VIEW $-0.21 -- REFINITIV IBES DATA
Source text for Eikon: ID:nBwcK2yCa
Further company coverage: DMAC.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on DiaMedica Therapeutics
See all newsBrief: Diamedica Therapeutics Announces Enrollment Of 200Th Patient In Remedy2 Phase 2/3 Acute Ischemic Stroke Trial
DiaMedica Q2 net loss widen less than expected
DiaMedica Therapeutics Inc expected to post a loss of 20 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Qualcomm, Robinhood
Brief: Diamedica Receives FDA Feedback On Dm199 Preeclampsia Nonclinical Program